Divendres, 3 de juny de 2022 | 08:00h | Auditori | l'Acadèmia Can Caralleu
Inscripcions
Doc. Cessió CAT
03-06-2022 | Auditori
08:30 - 09:00 Accreditation and material delivery
09:00 - 11:00 First session: AML biology and precision diagnosis
| Moderador/a: Jordi Esteve Reyner | |
|
Hospital Clínic de Barcelona |
|
Mutational landscape of AML
| Ponent: Verena Gaidzik | |
|
University Hospital of Ulm, Germany |
Germline predisposition to myeloid neoplasms
| Ponent: Marta Pratcorona | |
|
Hospital de la Santa Creu i Sant Pau |
Measurable residual disease: development of precision tools for treatment decision
| Ponent: Peter Valk | |
|
Erasmus University Medical Center, Rotterdam |
Clinical case: challenging diagnosis
| Ponent: Àlex Bataller | |
|
Hospital Clínic de Barcelona |
11:00 - 11:30 Coffee break
11:30 - 13:30 Second session: targeted therapy for chemotherapy eligible patients
| Moderador/a: Ana Garrido Díaz | |
|
Hospital de la Santa Creu i Sant Pau |
|
Frontline therapy with targeted agents
| Ponent: Marina Diaz Beya | |
|
Hospital Clínic de Barcelona |
Salvage therapy option in the targeted therapy era
| Ponent: Mar Tormo | |
|
Hospital Clínico Universitario de Valencia |
Allogeneic hematopoietic cell transplantation in AML: To whom, hen and how?
| Ponent: Mi Kwon | |
|
Hospital General Universitario Gregorio Marañón, Madrid |
Clinical case: R/R AML
| Ponent: Olga Salamero García | |
|
Hospital Universitari Valle de Hebrón, Barcelona |
13:30 - 14:30 Lunch
14:30 - 16:30 Third session: therapy for chemotherapy ineligible patients
| Moderador/a: Ana Garrido Díaz | |
|
Hospital de la Santa Creu i Sant Pau |
|
| Moderador/a: Jordi Esteve Reyner | |
|
Hospital Clínic de Barcelona |
|
Clonal evolution in AML: from CHIP to clonal response and beyond
| Ponent: Josep Nomdedéu | |
|
Hospital de la Santa Creu i Sant Pau, Barcelona |
Venetoclax+hypomethylating agents and beyond: time for triplets & more?
| Ponent: Courtney DiNardo | |
|
University of Texas MD Anderson Cancer Center, Houston |
How to manage failure to venetoclax?
| Ponent: Montserrat Arnan Sangerman | |
|
ICO Hospital Duran i Reynals, Barcelona |
Clinical case: therapy for chemotherapy-ineligible patients
| Ponent: Susana Vives | |
|
ICO- H. Germans Trias i Pujol |
16:30 - 17:30 Homenatge de la Societat Catalana d’Hematologia i Hemoteràpia al Dr. Jordi Sans i Sabrafen
Presentació
| Presentador/a: Albert Altés Hernández | |
Aspectes científics
| Ponent: Joan Vives-Corrons | |
El Dr. Jordi Sans i l’Escola d’Hematologia “Farreras-Valentí”
| Ponent: Evarist Feliu | |
Aspectes humans
| Ponent: Soledad Woessner | |
Cloenda de la sessió
17:30 - 18:00 Assembla General Ordinària
Presentació de la memòria d'activitats i econòmica de la SCHH 2021-2022.
| Presentador/a: Albert Altés Hernández | |
| Presentador/a: Carlos Fernández de Larrea Rodríguez | |
Presentació del guanyador/a de la (número de la beca) beca Janssen.
| Presentador/a: Laura Carola Magnano Mayer | |
Resultat de les eleccions de la Junta de la SCHH.
| Presentador/a: Laura Magnano | |
18:00 - 18:10 Closure of the meeting